Acting on sex and gender in medical innovation is good for business
Author Department
Emergency Medicine
Document Type
Article, Non peer-reviewed
Publication Date
6-2023
Abstract
Lavanya Vijayasingham and colleagues argue that as well as improving safety and efficacy, considering sex and gender related factors in medical research can have commercial benefits.
Recommended Citation
Vijayasingham L, Bischof E, Ateghang-Awankem B, Rumaney M, Otmani Del Barrio M, Cheah PY, Ter-Meulen AS, Tannenbaum C, Morgan R, Wolfe J; Gender and Covid-19 Research Agenda Setting Initiative. Acting on sex and gender in medical innovation is good for business. BMJ. 2023 Jun 7;381:e072242. doi: 10.1136/bmj-2022-072242.
PMID
37286208
COinS